EP Patent

EP4046630A1 — Tts-formulation with thc

Assigned to LTS Lohmann Therapie Systeme AG · Expires 2022-08-24 · 4y expired

What this patent protects

Disclosed is a transdermal therapeutic system comprising an active agent impermeable backing layer, at least one adhesive layer comprising at least 70% by weight of at least one polysiloxane polymer, at least one tetrahydrocannabinol (THC) and at least one solubilizer, and option…

USPTO Abstract

Disclosed is a transdermal therapeutic system comprising an active agent impermeable backing layer, at least one adhesive layer comprising at least 70% by weight of at least one polysiloxane polymer, at least one tetrahydrocannabinol (THC) and at least one solubilizer, and optionally a protective layer for removal before use, a method for its preparation and its use as a medicament.

Drugs covered by this patent

Patent Metadata

Patent number
EP4046630A1
Jurisdiction
EP
Classification
—
Expires
2022-08-24
Drug substance claim
No
Drug product claim
No
Assignee
LTS Lohmann Therapie Systeme AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.